SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley

News Feed Item

Talyst Launches AutoVault™ At ASHP 2013

KIRKLAND, Wash., Dec. 8, 2013 /PRNewswire/ -- Talyst, a leader in pharmacy automation, will launch AutoVault™ at the 2013 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Orlando. The new technology provides controlled access and secure management of CII medications. AutoVault securely stores, tracks and monitors the picking and restocking of controlled substance inventory.

AutoVault is fully integrated with AutoPharm Enterprise software, allowing easy integration with existing pharmacy automation. The technology's accurate and easily retrievable real-time data helps effectively manage controlled substance inventory.

"AutoVault's full integration with AutoPharm Enterprise allows pharmacists to manage their entire medication inventory with one software platform," said Carla Corkern, Chief Executive Officer at Talyst.

The ASHP Midyear Clinical Meeting & Exhibition will be held at the Orange County Convention Center in Orlando, FL (December 9-12).  Talyst will be exhibiting in booth #1447. For more information about the conference and sessions, visit http://connect.ashp.org/MCM13/Home/.

About Talyst 
Talyst, a leader in pharmacy automation, helps pharmacies enhance efficiency, provide greater inventory control and improve patient safety by delivering enterprise-class software and proven hardware components. Talyst's solutions manage medications across the entire health system. As of 2013, Talyst has installed automated systems in more than 600 acute-care hospitals, integrated healthcare systems, long-term care facilities, and correctional institutions. Talyst engineers the safer pharmacy and is your expert partner in complex pharmacy operations. Follow us on Twitter @Talyst_Inc, and for more information, visit, www.talyst.com.

SOURCE Talyst

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.